OSX2:XETRA:XETRA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) EUR (EUR)

ETF | Others |

Last Closing

USD 280.4

Change

+1.40 (+0.50)%

Market Cap

N/A

Volume

2.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.33 (+0.73%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.45 (+0.49%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.15 (+0.64%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.08 (+0.60%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.03 (+0.48%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.15 (+0.65%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.07 (+0.56%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.31 (-0.55%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.03 (+0.30%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.05 (-0.04%)

USD 12.26B

ETFs Containing OSX2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.91% 31% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.91% 35% F 34% F
Trailing 12 Months  
Capital Gain 2.02% 47% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.02% 49% F 50% F
Trailing 5 Years  
Capital Gain 41.25% 48% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.25% 50% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 9.33% 63% D 63% D
Dividend Return 9.33% 61% D- 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.66% 63% D 71% C-
Risk Adjusted Return 96.65% 84% B 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike